What the buyer wrote
NHS National Pharmaceuticals Transition 2020_2 Offer reference number: CM/PHG/20/5618 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months) Potential periods of call-offs under the framework agreement Transition Products: LSNE 01/12/2020 to 30/09/2021 (10 months) NWLN 01/12/2020 to 31/01/2022 (14 months) CESW 01/12/2020 to 30/06/2022 (19 months) Hospital Only Products: All Regions 01/12/2020 to 31/01/2022 (14 months)
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS National Pharmaceuticals Transition 2020_2
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 1 Dec 2020
- Work ends
- 30 Jun 2022
- Kind of work
- Pharmacy and medicines
Who the buyer named
NHSE Commercial was the named contact on this notice.
